- LGP2 (Laboratory of Genetics and Physiology 2) is the third member of the RIG‑I‑like receptor (RLR) family, alongside RIG‑I and MDA5. Unlike its counterparts, LGP2 does not contain CARD domains and therefore cannot directly activate MAVS or initiate interferon signalling. Instead, LGP2 functions as a regulatory RNA sensor, fine‑tuning the activity of RIG‑I and MDA5 to ensure accurate antiviral responses. This modulatory role makes LGP2 essential for balancing sensitivity and specificity in innate immunity.
- Structurally, LGP2 contains a helicase domain and a C‑terminal regulatory domain that bind viral RNA with high affinity. Although it lacks the CARD domains required for downstream signalling, LGP2 uses its RNA‑binding ability to influence how RIG‑I and MDA5 interact with viral RNA. In the context of RIG‑I, LGP2 can either enhance or suppress signalling depending on the type of RNA encountered. For short 5′‑triphosphorylated RNAs, LGP2 often acts as a negative regulator, preventing excessive activation. For more complex RNA structures, LGP2 stabilises RIG‑I binding and supports efficient signalling.
- LGP2 plays an even more prominent role in regulating MDA5, the sensor of long viral dsRNA. MDA5 activation requires filament formation along extended RNA molecules, and LGP2 enhances this process by stabilising MDA5 filaments and promoting cooperative assembly. Without LGP2, MDA5 signalling becomes inefficient, leading to weaker interferon responses against viruses such as picornaviruses and coronaviruses. In this way, LGP2 acts as a molecular chaperone that ensures MDA5 responds only when viral replication produces sufficiently long dsRNA structures.
- The regulatory behaviour of LGP2 is essential for preventing inappropriate immune activation. By modulating RIG‑I and MDA5, LGP2 helps maintain a balance between antiviral defence and avoidance of autoimmunity. Dysregulation of LGP2 has been linked to abnormal interferon production and inflammatory disorders, highlighting its importance in immune homeostasis. LGP2 also participates in broader RNA‑related processes, including modulation of RNA stability and interactions with viral replication complexes.
- Many viruses attempt to evade LGP2‑mediated regulation. Some viral proteins bind directly to LGP2 to block its RNA‑binding ability, while others alter the structure of viral RNA to avoid detection. These strategies underscore the significance of LGP2 as a checkpoint in antiviral immunity.
- In summary, LGP2 is a unique regulatory RNA sensor that modulates the activity of RIG‑I and MDA5 rather than directly activating antiviral signalling. Its ability to stabilise MDA5 filaments and fine‑tune RIG‑I responses ensures precise detection of viral RNA and prevents harmful immune overactivation. Through this regulatory role, LGP2 remains a key component of innate immunity and an important subject in virology and immunological research.
